Skip to main content
. 2016 Apr 26;11(4):e0153323. doi: 10.1371/journal.pone.0153323

Table 1. Total genomic disruption in relation to clinical and histopathological variables.

Independent variable Descriptive statistics Hypothesis testing p-value
Age at diagnosis (months) Mean ± SEM <2.20E-016* (WRST)
Q1 (25% least disrupted tumors) 8 ± 1.4 months
Q2 14 ± 1.8 months
Q3 26 ± 2.6 months
Q4 (25% most disrupted tumors) 38 ± 3.4 months
Laterality # genes with SCNAs: 8.16E-008* (WRST)
bilateral 1267 ± 230 genes
unilateral 2845 ± 223 genes
Heredity # genes with SCNAs: 0.0045* (WRST)
hereditary 1618 ± 252 genes
non-hereditary 2752 ± 285 genes
Differentiation grade # genes with SCNAs: 0.046* (LBL)
well 1998 ± 490 genes
moderate 3307 ± 523 genes
poor 3556 ± 420 genes
FW-rosettes # genes with SCNAs: 0.048 (WRST)
yes 1293 ± 327 genes
no 2661 ± 844 genes
Focality # genes with SCNAs: 0.1144 (WRST)
multifocal 1016 ± 157 genes
unifocal 2650 ± 658 genes
Volume measured by MRI (mm3) Mean ± SEM 0.1828 (WRST)
Q1 (25% least disrupted tumors)Q2 1028 ± 91 mm3976 ± 123 mm3
Q3 773 ± 153 mm3
Q4 (25% most disrupted tumors) 1120 ± 173 mm3
Sex # genes with SCNAs: 0.2191 (WRST)
male 2732 ± 278 genes
female 2231 ± 228 genes
Rosettes # genes with SCNAs: 0.4004 (WRST)
yes 1325 ± 225 genes
no 2303 ± 986 genes
Familiarity # genes with SCNAs: 0.4437 (WRST)
familial 1045 ± 651 genes
non-familial 1507 ± 220 genes
Invasion # genes with SCNAs: 0.5951 (WRST)
invasive 3094 ± 326 genes
non-invasive 2939 ± 457 genes

Tested variables are sorted by statistical significance. Q1-4 denote cohort quartiles based on the number of genes whose copy number is altered where Q1 denotes the cohort quartile with the least copy number altered genes and Q4 the cohort quartile with the most copy number altered genes. WRST-Wilcoxon rank-sum test, LBL = Linear-by-linear.

* indicates significance (p-value < 0.05). P-values lower than 0.001 are given in scientific notation.